Posted by
FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety

FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety

Agency is expediting work to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD Today, the U.S. Food and Drug Administration announced that it has issued a warning letter to Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid […]

Posted by
Cannabis: Doctors tell FDA to get out of the weeds

Cannabis: Doctors tell FDA to get out of the weeds

Publish date: May 31, 2019 By Kari Oakes  Clinical Neurology News FROM AN FDA PUBLIC HEARING The Food and Drug Administration held its first-ever public hearing about products containing cannabis or cannabis-derived compounds – and it got an earful. Hearing from over 100 individuals, the all-staff FDA panel was asked repeatedly to take the lead in bringing order […]

Posted by
Marijuana during prenatal OUD treatment increases premature birth

Marijuana during prenatal OUD treatment increases premature birth

Publish date: April 28, 2019By M. Alexander Otto REPORTING FROM PAS 2019 BALTIMORE – Marijuana is a not a good idea during pregnancy, and it’s an even worse idea when women are being treated for opioid addiction, according to an investigation from East Tennessee State University, Mountain Home. Marijuana use may become more common as legalization rolls out […]

Posted by
More evidence links high-potency marijuana use to first-episode psychosis

More evidence links high-potency marijuana use to first-episode psychosis

Publish date: December 14, 2017 By Randy Dotinga Clinical Psychiatry News SAN DIEGO – High-potency marijuana use appears to be associated with an increased risk of a first psychotic episode, based on a case-control study conducted in Europe. “Daily users of a strong type of cannabis face a significant increase in the probability of developing a psychotic disorder,” reported […]